MIRM - Mirum Pharmaceuticals GAAP EPS of -$0.57 revenue of $47.7M November, 02 2023 04:51 PM Mirum Pharmaceuticals Inc. 2023-11-02 16:51:04 ET Mirum Pharmaceuticals press release ( NASDAQ: MIRM ): Q3 GAAP EPS of -$0.57. Revenue of $47.7M (+153.7% Y/Y). For further details see: Mirum Pharmaceuticals GAAP EPS of -$0.57, revenue of $47.7M